DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $627,000 | -21.4% | 13,984 | 0.0% | 0.09% | -24.8% |
Q4 2020 | $798,000 | -21.5% | 13,984 | -29.4% | 0.12% | -54.0% |
Q3 2020 | $1,016,000 | +146.6% | 19,800 | +97.9% | 0.27% | +78.9% |
Q1 2020 | $412,000 | +32.5% | 10,007 | +100.1% | 0.15% | +216.7% |
Q4 2019 | $311,000 | – | 5,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |